352 related articles for article (PubMed ID: 26042393)
1. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
[TBL] [Abstract][Full Text] [Related]
2. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.
Musich S; Cheng Y; Wang SS; Hommer CE; Hawkins K; Yeh CS
J Gen Intern Med; 2015 Aug; 30(8):1208-14. PubMed ID: 25666213
[TBL] [Abstract][Full Text] [Related]
4. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.
Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM
J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981
[TBL] [Abstract][Full Text] [Related]
5. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018.
Li M; Bounthavong M
J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087
[No Abstract] [Full Text] [Related]
6. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
Madden JM; Graves AJ; Zhang F; Adams AS; Briesacher BA; Ross-Degnan D; Gurwitz JH; Pierre-Jacques M; Safran DG; Adler GS; Soumerai SB
JAMA; 2008 Apr; 299(16):1922-8. PubMed ID: 18430911
[TBL] [Abstract][Full Text] [Related]
7. Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes.
He Q; Silverman CL; Park C; Tiu GF; Ng BP
J Manag Care Spec Pharm; 2021 Jun; 27(6):696-705. PubMed ID: 34057396
[No Abstract] [Full Text] [Related]
8. Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma.
Prager AJ; Liebmann JM; Cioffi GA; Blumberg DM
JAMA Ophthalmol; 2016 Apr; 134(4):357-65. PubMed ID: 26747060
[TBL] [Abstract][Full Text] [Related]
9. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
[TBL] [Abstract][Full Text] [Related]
10. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
McWilliams JM; Zaslavsky AM; Huskamp HA
JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
Wei II; Lloyd JT; Shrank WH
J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
[TBL] [Abstract][Full Text] [Related]
12. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
13. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
[TBL] [Abstract][Full Text] [Related]
14. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.
Zivin K; Madden JM; Graves AJ; Zhang F; Soumerai SB
Am J Geriatr Psychiatry; 2009 Dec; 17(12):1068-76. PubMed ID: 20104063
[TBL] [Abstract][Full Text] [Related]
15. Unfilled Prescriptions of Medicare Beneficiaries: Prevalence, Reasons, and Types of Medicines Prescribed.
Kennedy J; Tuleu I; Mackay K
J Manag Care Spec Pharm; 2020 Aug; 26(8):935-942. PubMed ID: 32715958
[TBL] [Abstract][Full Text] [Related]
16. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
[TBL] [Abstract][Full Text] [Related]
17. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
[TBL] [Abstract][Full Text] [Related]
18. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Frankenfield DL; Howell BL; Wei II; Anderson KK
Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
[TBL] [Abstract][Full Text] [Related]
19. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
Urmie JM; Farris KB; Doucette WR; Goedken AM
J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
[TBL] [Abstract][Full Text] [Related]
20. Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma.
Gupta D; Ehrlich JR; Newman-Casey PA; Stagg B
Ophthalmol Glaucoma; 2021; 4(2):126-130. PubMed ID: 32841767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
